Impact of fluorodeoxyglucose PET on the management of esophageal cancer. Nuclear Medicine Communications

Salavati, A.Basu, SandipHeidari, P.Alavi, A.2010-08-122010-08-122009http://hdl.handle.net/123456789/34634147 bytestext/htmlen18F-fluorodeoxyglucoseesophageal neoplasmsneoadjuvant therapyneoplasm stagingpositron emission tomographyprognosisImpact of fluorodeoxyglucose PET on the management of esophageal cancer. Nuclear Medicine CommunicationsArticle